Newly Developed Recombinant Antithrombin Protects the Endothelial Glycocalyx in an Endotoxin-Induced Rat Model of Sepsis

(1) Background: The endothelial glycocalyx is a primary target during the early phase of sepsis. We previously reported a newly developed recombinant non-fucosylated antithrombin has protective effects in vitro. We further evaluated the effects of this recombinant antithrombin on the glycocalyx dama...

Descripción completa

Detalles Bibliográficos
Autores principales: Iba, Toshiaki, Levy, Jerrold H., Aihara, Koichiro, Kadota, Katsuhiko, Tanaka, Hiroshi, Sato, Koichi, Nagaoka, Isao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795760/
https://www.ncbi.nlm.nih.gov/pubmed/33375342
http://dx.doi.org/10.3390/ijms22010176

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795760/
https://www.ncbi.nlm.nih.gov/pubmed/33375342
http://dx.doi.org/10.3390/ijms22010176

Ejemplares similares